[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Priyanka Sharma\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100562471",false,"NCT06603597","HER2-positive Breast Cancer Registry","Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)","PRO-HER2","Inclusion Criteria:\n\n* Stage I-IV HER2-positive breast cancer\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","10 Years","OBSERVATIONAL","The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.",[25],"HER2 + Breast Cancer",[27,28,29,30],"breast cancer","registry","HER2+","HER2 positive","RECRUITING","2025-09-02",{"date":34,"type":35},"2025-09-10","ACTUAL",{"date":37,"type":35},"2024-09-27",{"date":39,"type":20},"2044-10",{"name":41,"class":42},"Priyanka Sharma","OTHER",6,""]